Landfar Bio-medicine: Announcement of the Progress of Legal Proceedings Regarding the Controlling Subsidiary of Landfar Bio-Medicine
Landfar Bio-medicine: Announcement of Landfar Bio-Medicine on Filing a Lawsuit against Its Subsidiary
Landfar Bio-medicine: 2024 Interim Performance Forecast
Landfar Bio-medicine: Announcement on the Progress of Litigation Matters of Subsidiary Controlled by Landfar Bio-Medicine
Landfar Bio-medicine: Announcement of abnormal fluctuations in the trading of Landfar Bio-Medicine stocks.
Landfar Bio-medicine: Legal Opinion on Nanhua Biotech's 2023 Annual General Meeting of Shareholders
Landfar Bio-medicine: Announcement of Resolutions of Nanhua Biotech's 2023 Annual General Meeting of Shareholders
Landfar Bio-medicine: Nanhua Biotech Stock Trading Abnormal Fluctuation Notice
Landfar Bio-medicine: Announcement of Nanhua Biotech on changing the registered capital, amending the “Articles of Association”, and completing the registration of industrial and commercial changes
Landfar Bio-medicine: Nanhua Biotech Stock Trading Abnormal Fluctuation Notice
Landfar Bio-medicine: Nanhua Biotech's announcement on uncompensated losses exceeding one-third of the total paid-up share capital in 2023
Landfar Bio-medicine: Western Securities Co., Ltd. inspection opinions on the 2023 internal control self-evaluation report of Nanhua Biopharmaceutical Co., Ltd.
Landfar Bio-medicine: 2023 Annual Report Summary
Landfar Bio-medicine: Report on the work of the board of directors of Nanhua Biotech 2024
Landfar Bio-medicine: Nanhua Biotech 2023 Supervisory Board Work Report
Landfar Bio-medicine: Western Securities Co., Ltd.'s inspection opinion on Nanhua Biopharmaceutical Co., Ltd.'s 2024 daily related transaction forecast
Landfar Bio-medicine: Special explanation on the occupation of non-operating capital and other related capital transactions in 2023
Landfar Bio-medicine: Special instructions on the use of funds raised in the year
Landfar Bio-medicine: Western Securities Co., Ltd.'s inspection opinion on Nanhua Biopharmaceutical Co., Ltd.'s use of idle funds to entrust financial management and related transactions
Landfar Bio-medicine: Nanhua Biotech's announcement on the use of idle funds for entrusted financial management and related transactions
No Data